Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/103306
Title: Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Authors: Leibiger, Ingo B.
Leibiger, Barbara
Moede, Tilo
Paschen, Meike
Dicker, Andrea
Abdulreda, Midhat H.
Åvall, Karin
Ali, Yusuf
Daré, Elisabetta
Köhler, Martin
Ilegems, Erwin
Graham, Mark
Crooke, Rosanne M.
Tay, Vanessa Shi Yun
Refai, Essam
Nilsson, Stefan K.
Jacob, Stefan
Selander, Lars
Berggren, Per-Olof
Juntti-Berggren, Lisa
Keywords: diabetes
apoCIII
insulin resistance
pancreatic islets
Issue Date: 2015
Source: Åvall, K., Ali, Y., Leibiger, I. B., Leibiger, B., Moede, T., Paschen, M., et al. (2015). Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes. Proceedings of the National Academy of Sciences of the United States of America, 112(20), E2611-E2619.
Series/Report no.: Proceedings of the National Academy of Sciences of the United States of America
Abstract: Insulin resistance and β-cell failure are the major defects in type 2 diabetes mellitus. However, the molecular mechanisms linking these two defects remain unknown. Elevated levels of apolipoprotein CIII (apoCIII) are associated not only with insulin resistance but also with cardiovascular disorders and inflammation. We now demonstrate that local apoCIII production is connected to pancreatic islet insulin resistance and β-cell failure. An increase in islet apoCIII causes promotion of a local inflammatory milieu, increased mitochondrial metabolism, deranged regulation of β-cell cytoplasmic free Ca2+ concentration ([Ca2+]i) and apoptosis. Decreasing apoCIII in vivo results in improved glucose tolerance, and pancreatic apoCIII knockout islets transplanted into diabetic mice, with high systemic levels of the apolipoprotein, demonstrate a normal [Ca2+]i response pattern and no hallmarks of inflammation. Hence, under conditions of islet insulin resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of β-cell function and may thus constitute a novel target for the treatment of type 2 diabetes mellitus.
URI: https://hdl.handle.net/10356/103306
http://hdl.handle.net/10220/25742
DOI: http://dx.doi.org/10.1073/pnas.1423849112
Rights: © 2015 The Author(s) (Published by National Academy of Sciences).This is the author created version of a work that has been peer reviewed and accepted for publication by Proceedings of the National Academy of Sciences of the United States of America, The Author(s) (Published by National Academy of Sciences). It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1073/pnas.1423849112].
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes.pdf1.28 MBAdobe PDFThumbnail
View/Open

Google ScholarTM

Check

Altmetric

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.